Clinical Trial Update: 4-aminopyridine Treatment for Nerve Injury [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update indicates Phase 2/3 study of 4-aminopyridine for nerve injury is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nerve Injury
• Prostate Cancer

Drugs mentioned

• 4-aminopyridine (4-aminopyridine)

Snippet

Sponsor: John Elfar | Conditions: Nerve Injury, Prostate Cancer | Phase 2, Phase 3 | Status: RECRUITING